当前位置: 首页 > 详情页

Type A aortic dissection with arch entry tear: Surgical experience in 104 patients over a 12-year period

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, Beijing Inst Heart Lung & Blood Vessel Dis,Beijin, Beijing, Peoples R China; [2]Beijing Engn Res Ctr Vasc Prostheses, Beijing, Peoples R China; [3]Fu Wai Hosp, Beijing 100730, Peoples R China; [4]Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [5]Yale Univ, Sch Med, Aort Inst Yale New Haven, New Haven, CT USA; [6]SUNY Stony Brook, Dept Econ, Stony Brook, NY USA; [7]SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY USA; [8]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, 2 Anzhen Rd, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: aorta thoracic/surgery aortic dissection blood vessel prosthesis treatment outcome mortality Kaplan-Meier estimate

摘要:
Objective: To evaluate the efficacy of the frozen elephant trunk (FET) and total arch replacement (TAR) technique (FET + TAR) in the management of type A aortic dissection (TAAD) with arch entry tear. Methods: Clinical outcomes were analyzed for 104 TAAD patients with arch entry tear undergoing FET + TAR at 4.7 +/- 3.5 days from symptom onset and compared with 728 TAAD patients with entry tears in elsewhere. The mean patient age was 49.3 +/- 9.3 years, compared with 45.6 +/- 10.8 years in other TAAD patients (P < .001). There were 84 men (80.8%). Hypertension was seen in 84.6% (88/104). Results: Operative mortality was 8.6% (9/104). Spinal cord injury occurred in 3 cases (2.9%), stroke in 2 (1.9%), renal failure in 4 (3.8%) and limb ischemia in 2 (1.9%). Follow-up was 100% (95/95) at mean 5.6 +/- 2.6 years (range 1.3-11.6). Late death occurred in 2 cases (1.9%). Survival and freedom from late adverse events were 89.2% (95% confidence interval [CI], 81.3%-93.9%) and 85.0% (95% CI, 76.3%-90.8%) at 8 years, respectively. Both the stented and unstented distal aortic segments showed significant trends of false lumen shrinkage and true lumen expansion over time (P < .001). Of the 65 CT scans at mean 4.6 +/- 2.9 years postoperatively, the false lumen was completely obliterated in 63. Risk factors for arch entry tear were hypertension (odds ratio [OR], 2.091; 95% CI, 1.186-3.687; P = .011) and age (OR, 1.025; 95% CI, 1.002-1.048; P = .032). Conclusions: TAAD with arch entry tear was treated safely and durably by FET + TAR. Although patients with arch entry tear were somewhat older than other patients, operative mortality was not substantially higher despite their older age and arch location of entry tear. These results argue favorably for the use of the FET + TAR technique in the management of TAAD patients with arch entry tears.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 2 区 医学
小类 | 2 区 呼吸系统 2 区 外科 3 区 心脏和心血管系统
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 外科 2 区 心脏和心血管系统 2 区 呼吸系统
JCR分区:
出版当年[2014]版:
Q1 RESPIRATORY SYSTEM Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Q1 SURGERY
最新[2023]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Q1 RESPIRATORY SYSTEM Q1 SURGERY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, Beijing Inst Heart Lung & Blood Vessel Dis,Beijin, Beijing, Peoples R China; [2]Beijing Engn Res Ctr Vasc Prostheses, Beijing, Peoples R China; [3]Fu Wai Hosp, Beijing 100730, Peoples R China; [4]Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [5]Yale Univ, Sch Med, Aort Inst Yale New Haven, New Haven, CT USA;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, Beijing Inst Heart Lung & Blood Vessel Dis,Beijin, Beijing, Peoples R China; [2]Beijing Engn Res Ctr Vasc Prostheses, Beijing, Peoples R China; [3]Fu Wai Hosp, Beijing 100730, Peoples R China; [4]Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [8]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, 2 Anzhen Rd, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院